Avid Therapeutics, Inc.
SBIR Phase I
STTR Phase I
There are 300 million people in the world who are chronically infected with hepatitis B virus (HBV). Available therapies for the elimination of HBV infection often have a transient effect only. These ...SBIR Phase I 1993 Department of Health and Human Services
N/ASTTR Phase I 1998 Department of Health and Human Services